Sort   by:  
 Page size 
The paired-end next-generation sequencing of all small RNAs of less than 200 nucleotides in length from four different human cell lines (SKOV3ip1, MCF-7, BJ-Tielf, INOF) allowed us to determine the exact sequence(s) and variations of human box C/D snoRNAs (small nucleolar RNAs), revealing processing...
ORGANISM(S): Homo sapiens 
This SuperSeries is composed of the following subset Series: GSE15193: IFN-alpha Stimulated Gene Expression in Sensitive and Resistant Renal Cell Carcinoma Cell Lines GSE16196: Differential IFNa-stimulated gene expression profiles in PLZF-inducible U937T monocyte cells Refer to individual Series
ORGANISM(S): Homo sapiens 
The snoMEN (snoRNA Modulator of gene ExpressioN) vector technology was developed from a human box C/D snoRNA, HBII-180C, which contains an internal sequence that can be manipulated to make it complementary to RNA targets, allowing knock-down of targeted genes. Here we have screened additional human ...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2017-03-31 | MSV000080828 | MassIVE
abundance based on Protein peptide count, Interaction consistency score: 1.8, Coverage: 6
ORGANISM(S): 10090 
2006-00-00 | 2752498147 | PAXDB
abundance based on Protein peptide count, Interaction consistency score: 2.8, Coverage: 6
ORGANISM(S): 10090 
2006-00-00 | 768744604 | PAXDB
abundance based on Protein peptide count, Interaction consistency score: 2.5, Coverage: 6
ORGANISM(S): 10090 
2006-00-00 | 1029310712 | PAXDB
abundance based on Protein peptide count, Interaction consistency score: 0.6, Coverage: 9
ORGANISM(S): 10090 
2006-00-00 | 1059798720 | PAXDB
abundance based on Protein peptide count, Interaction consistency score: 0.6, Coverage: 10
ORGANISM(S): 10090 
2006-00-00 | 3806477322 | PAXDB
abundance based on Protein peptide count, Interaction consistency score: 0.7, Coverage: 8
ORGANISM(S): 10090 
2006-00-00 | 1458147558 | PAXDB
Cytogenetically normal acute myeloid leukemia (CN-AML) represents nearly 50% of human acute myeloid leukemia (AML) cases with a 5-year overall survival of approximately 30%. In CN-AML with poorer prognosis, mutations in the de novo DNA methyltransferase (DNMT3A) and the FMS-like tyrosine kinase 3 (F...
ORGANISM(S): Mus musculus 
Sort   by:  
 Page size